Back to 
Morgan Stanley
Morgan Stanley
KPTI
6 quarters
Position history for Morgan Stanley's holdings in Karyopharm Therapeutics Inc.
Yes. Morgan Stanley holds 202,506 shares of KPTI (Karyopharm Therapeutics), worth $2M, as of its Q2 2026 13F filing. It increased the position from 18,570 shares in Q1 2026. Morgan Stanley has held KPTI in every 13F on record since Q1 2025, 6 quarterly filings.
Current Value
$2M
Current Shares
202,506
Total Value Change
+$1.9M
Total Shares Change
+192,083
Quarter-by-Quarter History
Other major holders of KPTI: RA Capital Management, L.P., Adage Capital Partners GP, L.L.C., Goldman Sachs Group Inc., BlackRock, Inc.